Dual immune checkpoint blockade found durable in melanoma

CHICAGO – Immune checkpoint blockade, especially with a combination of agents having complementary mechanisms of action, has durable efficacy when used as initial therapy for advanced melanoma, according to an update of the CheckMate 067 trial. The trial randomized 945 treatment-naive patients...
Source: Skin and Allergy News - Category: Dermatology Source Type: news